Patients with metabolic syndrome have been shown to have dysregulation of GLP1 and NO. Patients with asthma and metabolic syndrome may have a non-eosinophilic phenotype of asthma. Novel therapies are needed to treat this asthma phenotype. This evidence concerns the gene GCG and asthma.